The clinical trial, sponsored by the University of Southern Denmark, investigates the efficacy of the Protac MyFit® vest in enhancing participation and focus among children aged 6-12 with sensory processing disorder (SPD). The target market includes pediatric therapeutic devices aimed at improving sensory integration and attention in children, a segment that is gaining traction due to increasing awareness of SPD and related conditions. The collaboration with Protac A/S suggests potential commercial interest in the device, which may lead to future partnerships or licensing opportunities. The trial's outcomes could position the MyFit® vest as a viable intervention in educational and therapeutic settings, potentially influencing reimbursement strategies and market adoption. Competitive analysis indicates a growing number of interventions for SPD, necessitating a focus on unique selling propositions and clinical validation to differentiate from existing products.